Joshua D Robert

Mr. Joshua D Robert

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2026 in AI in Medicine
Verified
Journal Article
Open access
PDF file
RSRick Silva
Rick Silva
JTJian Tao
Jian Tao
SRSara Louise Rogers
Sara Louise Rogers
QHQiang He
Qiang He
JRJoshua D Robert
Joshua D Robert
Kenneth RamosKenneth Ramos
Kenneth Ramos
Digital twins (DTs) are dynamic, virtual representations of individual patients that could support predictive diagnostics and personalized therapeutic optimization. Their development depends on patient-level data from real-world data (RWD) sources and electronic medical record (EMR) data, but major barriers in data-stewardship, interoperability, provenance, and governance persist. This review examines critical bottlenecks within the current healthcare ecosystem, with particular attention to fragmented EMRs, limited longitudinal data continuity, and missing, incomplete, or inaccurate information. We address data availability, stewardship, and provenance rather than model construction itself. We also explore ethical imperatives of mitigating representational bias, where over-representation of European ancestry amplifies existing health inequalities. We evaluate blockchain technology as a decentralized trust anchor to ensure provenance, automate consent, and incentivize longitudinal data stewardship. In parallel, we acknowledge that clinically useful DTs also depend on substantial advances in model specification, calibration, and validation, especially for biologically complex diseases. By synthesizing computational, regulatory, and ethical challenges, we provide a roadmap for developing robust, equitable, and interoperable ecosystems for precision medicine.

10 November 2026 in Methodist DeBakey Cardiovascular Journal
Verified
Journal Article
Open access
PDF file
JRJoshua D Robert
Joshua D Robert
SBStephan Bannikov
Stephan Bannikov
AAAidan D. Atkins
Aidan D. Atkins
MRMaham Rahimi
Maham Rahimi
Aortic disease and lower-extremity peripheral artery disease (PAD) generate substantial morbidity, mortality, and longitudinal imaging burden. Artificial intelligence (AI) is increasingly studied for vascular risk prediction, image analysis, procedural support, and surveillance, but the maturity of these applications is heterogeneous. This review evaluates recent AI applications in aortic disease and PAD, emphasizing the distinction between algorithmic performance, external validation, demonstrated workflow impact, and proven patient benefit. Automated image segmentation and opportunistic abdominal aortic aneurysm (AAA) detection have the most mature evidence base, including retrospective external validation and, for AI-assisted AAA case finding, nonrandomized evidence of improved downstream evaluation and follow-up. Conversely, while machine-learning models for vascular risk prediction and disease progression often report high retrospective accuracy, their clinical readiness remains strictly investigational. Across most aortic and PAD applications, there is a persistent lack of independent external validation, decision-curve analysis, and prospective testing against standard care. Image-fusion guidance has clinical evidence for reducing procedural resource use, but this evidence should not be conflated with autonomous AI or robotic navigation. Cardiovascular digital twins remain largely mechanistic, computational, or early-development frameworks. AI can augment vascular imaging and risk assessment, but high retrospective accuracy is not equivalent to clinical utility. Current guideline thresholds for repair, revascularization, and surveillance should not be altered on the basis of investigational radiomics or prediction models. Translation requires multicenter external validation, prospective workflow evaluation, calibration and net-benefit assessment, transparent reporting, and trials demonstrating improved patient outcomes.